Author:
Kawaguchi Tatsuya,Nakakuma Hideki
Reference41 articles.
1. Hill A, Richards SJ, Hillmen P (2007) Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Br J Haematol 137 (3):181–192. doi: BJH6554 [pii] 10.1111/j.1365-2141.2007.06554.x
2. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A 96(9):5209–5214
3. Rosti V, Tremml G, Soares V, Pandolfi PP, Luzzatto L, Bessler M (1997) Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest 100(5):1028–1036. doi: 10.1172/JCI119613
4. Parker CJ (2002) Historical aspects of paroxysmal nocturnal haemoglobinuria: ‘defining the disease’. Br J Haematol 117 (1):3–22. doi:3374 [pii]
5. Horikawa K, Fujisao S, Iwamoto N, Nagakura S, Kawaguchi T, Nishimura Y, Takatsuki K, Nakakuma H (1996) Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria. Int J Hematol 63(2):165–166